NMP's product range includes GE HealthCare radiopharmaceuticals, which are essential for imaging in cardiology, oncology, and ...

GE Healthcare has identified radiopharmaceuticals as a growth driver for the company and Japan as a key market.

GE Healthcare to fully acquire Nihon Medi-Physics from Sumitomo Chemical, enhancing its radiopharmaceutical and molecular ...

GE HealthCare will acquire the remaining 50% stake in Nihon Medi-Physics, enabling it to fully own the Japanese ...

Check out who's buying and selling in this week's roundup of healthcare mergers, acquisitions and joint ventures.

Physics, maker of diagnostic radiopharmaceuticals and molecular imaging agents. | GE HealthCare plans to take full control of ...

Wall Street is chewing over data on Amgen’s weight loss injection, MariTde. Meanwhile, GE HealthCare will acquire a Japanese ...

GE HealthCare has owned half of Nihon Medi-Physics since 2004, when former parent company General Electric obtained the stake ...

GE HealthCare to acquire remaining 50% stake in Nihon Medi-Physics (NMP), a leading radiopharmaceutical company in Japan, ...

GE HealthCare (GEHC) has agreed to acquire the remaining 50% stake in Nihon Medi-Physics ((NMP)) from Sumitomo Chemical. Read ...

GE HealthCare to acquire 50% stake from Sumitomo Chemical to assume full ownership of NMP, subject to regulatory approvals As part of GE HealthCare, NMP, already a leading radiopharmaceutical ...